Most Recent
AFT loses challenge to ruling over ‘misleading’ Maxigesic ads
Competition & Consumer Protection 2020-03-19 9:07 pm By Cat Fredenburgh

AFT Pharmaceuticals has lost its challenge to a ruling that ads claiming its painkiller Maxigesic is more effective than Nuremol were misleading and deceptive, with the Full Federal Court saying the primary judge did not err in finding the ads lacked an adequate scientific basis.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Big riffin: Jay-Z sues Aussie co over play on ’99 Problems’ hook
Intellectual Property 2019-11-26 12:16 pm By Miklos Bolza

International hip-hop superstar Jay-Z has sued an Australian children’s book manufacturer for “flagrant, glaring and contumelious” intellectual property infringement with its ‘AB to Jay-Z’ baby books.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘We’re not in the realm of snake oil’: AFT appeals Maxigesic judgment
Competition & Consumer Protection 2019-08-13 9:02 pm By Miklos Bolza

AFT Pharmaceuticals has challenged a Federal Court decision that found its Maxisegic ads were misleading and deceptive, saying the judge “set the bar too high” by requiring it to prove there was an adequate scientific foundation for its painkiller representations.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Teva, Boehringer settle inhaler capsule patent dispute
Intellectual Property 2019-06-19 2:56 pm By Miklos Bolza

Israeli drug giant Teva and German drug maker Boehringer Ingelheim have settled their dispute over a patented capsule used to deliver the medicine in Boehringer’s top-selling inhaler Spiriva.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Mylan wants injunctions against Sun Pharma, Cipla over generic cholesterol drug
Intellectual Property 2019-03-06 3:17 pm By Christine Caulfield

Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Boehringer hits Teva with counterpunch in inhaler patent battle
Intellectual Property 2019-03-04 9:53 pm By Cat Fredenburgh

German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

D’Aquino Bros says it can prove its Scotch Whisky is the real deal
Intellectual Property 2018-12-10 9:01 pm By Christine Caulfield

Defending against a fourth trade mark infringement lawsuit by the UK’s Scotch Whisky Association, Australian liquor retailer D’Aquino Bros has told a court all of its Scotch Whisky was distilled in Scotland, and it has the paperwork to prove it.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Reckitt wants answers from AFT about Maxigesic ads
Competition & Consumer Protection 2018-11-22 8:22 pm By Miklos Bolza

Consumer goods giant Reckitt Benckiser is seeking more information after advertisements for rival AFT Pharmaceuticals’ Maxigesic painkiller were found in-store and online despite the court ordering the removal of the misleading displays earlier this month.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AFT Pharma ordered to pull misleading Maxigesic ads
Competition & Consumer Protection 2018-11-09 8:44 pm By Miklos Bolza

AFT Pharmaceuticals has been ordered to pull advertisements for its painkiller Maxigesic after the Federal Court ruled in favour of rival Reckitt Benckiser, finding the ads breached Australian Consumer Law.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?